Insider Trading June 12, 2026 02:11 PM

Globalfoundries CSO Executes $210K Share Divestiture Under Pre-Arranged Plan

Michael Hogan's transaction occurs as semiconductor firm advances AI and quantum initiatives, while stock posts 113% annual gain.

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
GFS

Michael James Hogan, Globalfoundries Inc. (NASDAQ: GFS) Chief Strategy Officer, executed a transaction involving the disposal of 2,800 ordinary shares valued at $210,476. The sale was facilitated through a Rule 10b5-1 trading plan on June 10, 2026, at a price of $75.17 per share. Concurrently, 150 ordinary shares were gifted under the same plan. Post-transaction, Hogan retains direct ownership of 6,545 ordinary shares. The stock has since appreciated to $81.87, reflecting a 9% increase from the sale price and a 113% gain over the trailing twelve months. Current valuation metrics suggest the equity may be trading above its fair value.

Globalfoundries CSO Executes $210K Share Divestiture Under Pre-Arranged Plan
GFS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Michael James Hogan, Globalfoundries Inc. (NASDAQ: GFS) Chief Strategy Officer, executed a transaction involving the disposal of 2,800 ordinary shares valued at $210,476. The sale was facilitated through a Rule 10b5-1 trading plan on June 10, 2026, at a price of $75.17 per share.
  • Globalfoundries has advanced several strategic corporate developments, including the completion of its acquisition of the Synopsys ARC Processor IP Solutions business and the launch of Quantum Technology Solutions.
  • The company entered into a strategic partnership with the U.S. Department of Energy’s Genesis Mission to facilitate AI chip development, enabling researchers to access GlobalFoundries’ U.S. manufacturing platform.

Michael James Hogan, serving as the Chief Strategy Officer for Globalfoundries Inc. (NASDAQ: GFS), has formally disclosed the execution of a share sale totaling $210,476. The transaction details were filed with the Securities and Exchange Commission (SEC), marking a significant insider activity event for the semiconductor manufacturer. Following the execution of this trade, the equity has demonstrated notable upward momentum, climbing to $81.87. This current price point represents a 9% appreciation from the $75.17 sale price and underscores a remarkable 113% gain over the past year.

On June 10, 2026, Mr. Hogan disposed of 2,800 ordinary shares at the specified price of $75.17 per share. In addition to the direct sale, the filing indicates that Mr. Hogan also reported gifting 150 ordinary shares on the identical date. Both the sale and the gift were executed pursuant to a Rule 10b5-1 trading plan. This regulatory framework permits company insiders to establish predetermined schedules for the buying or selling of company stock, providing a structured mechanism for portfolio management.

Following the completion of these transactions, Mr. Hogan's direct holding in Globalfoundries Inc. stands at 6,545 ordinary shares. Valuation analysis from InvestingPro suggests that the stock currently appears overvalued relative to its calculated Fair Value. Investors seeking deeper insights can access comprehensive analysis through the Pro Research Report, available for GFS and 1,400+ other US equities.

In parallel with this insider activity, Globalfoundries has advanced several strategic corporate developments. The company recently completed its acquisition of the Synopsys ARC Processor IP Solutions business. This transaction integrates the ARC processor IP business with MIPS, a subsidiary of GlobalFoundries, while Synopsys retains its interface and foundation IP portfolio. Furthermore, GlobalFoundries has entered into a strategic partnership with the U.S. Department of Energy’s Genesis Mission to facilitate AI chip development. This collaboration will enable Genesis Mission researchers to access GlobalFoundries’ U.S. manufacturing platform and design resources, with GF Labs leading the initiative.

Additional corporate developments include the launch of Quantum Technology Solutions, a new unit dedicated to manufacturing quantum computing hardware. This initiative will focus on producing quantum processor units and other components for quantum computing systems. In a separate market development, Mubadala Investment Co., Abu Dhabi’s sovereign wealth fund, raised $1.91 billion by selling a portion of its stake in GlobalFoundries. These recent developments highlight Globalfoundries’ ongoing efforts to expand its technological capabilities and strategic partnerships.

Key Points

  • Insider Transaction: CSO Michael Hogan sold 2,800 shares at $75.17 under a Rule 10b5-1 plan on June 10, 2026, and gifted 150 shares.
  • Corporate Expansion: Globalfoundries completed the acquisition of Synopsys' ARC Processor IP business and launched a new Quantum Technology Solutions unit.
  • Strategic Partnerships: A new collaboration with the U.S. Department of Energy’s Genesis Mission aims to accelerate AI chip development using GF Labs resources.

Risks and Uncertainties

  • Valuation Pressure: Current analysis indicates the stock may be overvalued relative to its Fair Value, potentially impacting near-term price stability.
  • Market Dynamics: The sale of a portion of its stake by Mubadala Investment Co. for $1.91 billion introduces additional supply-side considerations in the semiconductor sector.

Risks

  • Current valuation metrics from InvestingPro suggest that the stock appears overvalued relative to its Fair Value.
  • Mubadala Investment Co., Abu Dhabi’s sovereign wealth fund, raised $1.91 billion by selling a portion of its stake in GlobalFoundries, indicating institutional portfolio adjustments.

More from Insider Trading

Riley Exploration Permian CEO Executes $1.09 Million Stock Sale Amid Recent Earnings Disappointment Jun 12, 2026 Fidelity D & D Bancorp Chairman Cali Acquires Additional Shares Amid Strong Stock Performance Jun 12, 2026 Amalgamated Financial Director Divests $91,331 in Common Stock Amid Mixed Earnings Jun 12, 2026 IRIDEX CFO Romeo Dizon Acquires Additional Shares Amid Mixed Quarterly Results Jun 12, 2026 Summit Therapeutics Co-CEO Zanganeh Executes $49.98 Million Share Purchase Amid Market Volatility Jun 12, 2026